返回
InnoCare Pharma Limited（INCPF）价格
INCPF 股价走势图
INCPF 收益
InnoCare Pharma Limited
$2.05
0%
$0
收盘价：Jan 23, 16:00:00 GMT-5
$2.05
0%
$0
盘后：Jan 23, 20:00:00 GMT-5
最新收益结果： Q3 '25
报告： 2025-11-13
历史收益
季度性
年度
EPS
收入
Earnings FAQ
INCPF 最近的每股收益与预期相比如何？
InnoCare Pharma Limited INCPF 上一季度的收入表现如何？
InnoCare Pharma Limited 的收入预期是多少？
InnoCare Pharma Limited 的盈利质量评分是多少？
InnoCare Pharma Limited 何时发布财报？
InnoCare Pharma Limited 的预期收益是多少？
InnoCare Pharma Limited 是否超出收益预期？
关键数据
前收盘价
$2.05
开盘价
$2.05
当日区间
$2.05 - $2.05
52周范围
$2.05 - $3.26
交易量
1.0K
平均成交量
19
每股收益（TTM）
-0.02
股息收益率
--
市值
$3.0B
什么是 INNOCARE PHARMA LTD？
InnoCare Pharma Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Beijing, Beijing and currently employs 1,146 full-time employees. The company went IPO on 2020-03-23. InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The firm focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The firm's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The firm is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The firm conducts its businesses in domestic and overseas markets.